Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization (EUA) ...
A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...
Joint development strategy has been developed to address international deployment requirements if current outbreak continues or expands globally ...
A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of ...
Medical Device Network on MSN
Roche develops RUO PCR assay to detect rare Ebola Bundibugyo virus
TIB MOLBIOL developed the test using its "rapid response" library, with 15,000 designs and 3,000 controls.
Researchers at the Nebraska Public Health Laboratory worked round the clock to develop a test for the Andes virus at the center of the deadly cruise ship outbreak ...
PCR technology is a molecular diagnostics technology that detects target nucleic acids by amplifying the DNA amount. It has brought marked progress in the life sciences field since its development in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results